Bone Biologics Corp
BBLG· Nasdaq
BBLGBone Biologics Corp
Filed Aug 14, 2026 · 10-Q · 45 days after period end · 0001493152-26-038482
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Net Income | -$773.70K | -$740.52K | -$783.73K | -$1.77M |
| EPS Diluted | -$0.43 | -$1.33 | -$4.02 | -$5.21 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bone Biologics Corp · CIK 1419554 · Engraved from SEC EDGAR
ended Jun 30, 2026 · filed Aug 14, 2026 · 45 d after period end
